Bestchain Health

Bestchain Health is a Shanghai-based biotechnology company focused on leveraging artificial intelligence to discover novel small molecule drugs targeting protein-protein interactions (PPIs). The company's core technology, the BestChain platform, combines deep learning with physics-based simulations to tackle "undruggable" targets that traditional methods struggle to address. Their primary therapeutic focus areas include oncology and autoimmune diseases, where PPIs play a critical role in disease progression. Bestchain Health aims to significantly reduce the time and cost of drug development through its computational approach. The firm has attracted significant investment from prominent venture capital firms to advance its internal pipeline and platform capabilities. By integrating structural biology with advanced algorithms, the company seeks to unlock new therapeutic possibilities for complex diseases.